Spencer Phillips Hey

@SpencerPHey

Faculty ; founder . Research ethics, philosophy of science, health/science policy, data visualization and decision-making.

Vrijeme pridruživanja: rujan 2016.

Tweetovi

Blokirali ste korisnika/cu @SpencerPHey

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SpencerPHey

  1. Prikvačeni tweet
    16. kol 2018.

    Pleased to finally share the new website for my project on visualizing clinical trial data. Still a work-in-progress. Input, feedback, and suggestions welcome! (Sadly, these kinds of data-dense visualizations are not yet mobile-friendly. Best on desktop.)

    Poništi
  2. proslijedio/la je Tweet

    Great morning at Regsci Doctoral Student Symp! Great research around RCT design shortcomings, methods extrapolating patient level data, and FDA precert & digital pathology Thanks students and faculty

    Poništi
  3. proslijedio/la je Tweet
    3. velj

    Insulin was discovered a century ago but prices remain high. The VA negotiates with manufacturers but Medicare, by law, cannot. What if Congress allowed Medicare to negotiate insulin prices like the VA? We identify substantial savings.

    Poništi
  4. proslijedio/la je Tweet
    3. velj

    What are our obligations to research participants when an Alzheimer's trial stops early? and I have a new paper out in with our suggestions.

    Poništi
  5. proslijedio/la je Tweet

    Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands | Health Research Policy and Systems | Full Text

    , , i još njih 3
    Poništi
  6. proslijedio/la je Tweet
    28. sij

    In DC for the first in-person meeting! Great to have the Regulation and Ethics Core together. We’re excited to tackle ethical/regulatory issues that arise when conducting pragmatic trials to improve the lives of people living with dementia and their care partners.

    , , i još njih 4
    Poništi
  7. proslijedio/la je Tweet
    28. sij

    A really neat evidence synthesis that highlights the 'burden' of research on trial participants - identifies many modifiable aspects that can be tackled by good design & planning. Info provision across trial still a big problem - we MUST get better

    Poništi
  8. proslijedio/la je Tweet
    28. sij

    Proud to have been part of 's amazing research team. Here's our guide for (& families) who want to engage their hospital/system and have a voice in improving quality of care and outcomes.

    Poništi
  9. proslijedio/la je Tweet
    11. sij

    Important large meta-analysis of individual patient data in demonstrates that PFS is not a valid surrogate end point for OS in first-line treatment of advanced ovarian cancer, critical data to inform FDA approval decisions

    Poništi
  10. 9. pro 2019.

    Trends in philosophy jobs updated for 2019 . A few takeaways: Ethics still dominating. Uptick for phil science (40 tt jobs > 21 last year); bump for metaphysics (13 > 8); 6 tt jobs in data (typically ~1 per year, and for context, biology has only 3 jobs)

    Poništi
  11. proslijedio/la je Tweet
    2. pro 2019.

    New from our team: UNNATURAL EXPERIMENTS. Are we as says surrounded by a "large number of natural experiments" in untested government health programmes? In this Blog we examine ideas about and .

    , , i još njih 7
    Poništi
  12. proslijedio/la je Tweet
    25. stu 2019.

    Our latest via examines trial activity and finds considerable inefficiencies- Over 50% of trials were discontinued early or not published 4yrs after completion.

    Poništi
  13. proslijedio/la je Tweet
    Poništi
  14. proslijedio/la je Tweet
    7. stu 2019.
    , , i još njih 7
    Poništi
  15. proslijedio/la je Tweet
    5. stu 2019.

    Now you can get your very own Caretalk bear just in time for Diabetes Awareness Month! Half of the proceeds go to your choice of charity: either the Alzheimer's Association or the American Diabetes Association. You can buy them using the link here:

    Poništi
  16. proslijedio/la je Tweet
    28. lis 2019.

    JUST PUBLISHED: Adaptive trials, efficiency and ethics . "Some of the reasons why seem more attractive for patients may be based on misconceptions about what makes clinical trials ethical."

    Poništi
  17. proslijedio/la je Tweet
    28. lis 2019.

    Great research published from our team in , led by . We all know about the story of revoking of FDA approval of bevacizumab in breast cancer but what are the regulatory lessons from it?

    Prikaži ovu nit
    Poništi
  18. proslijedio/la je Tweet
    22. lis 2019.

    NEW commentary by Spencer Philips Hey (): 'Adaptive trials, efficiency, and ethics'.

    Prikaži ovu nit
    Poništi
  19. proslijedio/la je Tweet
    15. lis 2019.

    Only 12% of patients understood that the genetic testing done in their clinical trial would not tell them about their risk of other diseases. Thanks for your input on this study out of

    Poništi
  20. 11. lis 2019.

    Excited to be a part of the team, helping to shape this new health information and patient community platform!

    Poništi
  21. proslijedio/la je Tweet
    9. lis 2019.
    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·